JYJiaxin Yuan

Jiaxin Yuan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jiaxin Yuan has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Quantitative dual-layer spectral CT parameters associated with a continuous improvement response pattern to CAPTEM in advanced gastroenteropancreatic neuroendocrine neoplasms

    by Jiadan Luo, Ke Li, Siya Shi, Zujiang Shi, Tingting Wen, Jinhui Yu, Jiaxin Yuan, Jiawei Liu, Yanji Luo

    Objectives To evaluate the prognostic significance of a dynamic continuous improvement (CI) response pattern in gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) treated with capecitabine and temozolomide (CAPTEM), and to explore the association between baseline dual-layer spectral CT (DLCT) parameters and this favorable response trajectory. Methods This single-center retrospective study (May 2016 - September 2025) analyzed 54 patients treated with CAPTEM. Cox proportional hazards regression models were used to identify prognostic factors affecting progression-free survival (PFS). Patients were stratified via 9-month landmark analysis into CI and non-continuous improvement (NCI) groups. PFS and Time to Nadir (TTN) were compared. Baseline DLCT parameters were analyzed for their association with the CI pattern. Results 54 patients (median age, 53 years; 29 men) were evaluated. Peritumoral tissue invasion was independent prognostic factor (p = 0.008; Hazard Ratio [HR], 4.604; 95% confidence interval: 1.495, 14.173). In the landmark cohort, post-landmark PFS was significantly longer in the CI (n = 9) than the NCI (n = 13) group (18.70 vs. 6.47 months; HR, 0.295; 95% confidence interval: 0.100, 0.876; p = 0.044), with a longer TTN (9.67 vs. 6.83 months; p = 0.021). Lower baseline nIC and Zeff values were significantly associated with the CI pattern (median Zeff 8.070 vs. 8.920, p = 0.008; median nIC 0.426 vs. 0.723, p = 0.030). Conclusion The continuous improvement response pattern was associated with prolonged PFS in GEP-NENs treated with CAPTEM. Baseline DLCT parameters may help identify patients likely to derive sustained benefit from CAPTEM therapy.

  • Open Access

    Engineered bacterial extracellular vesicles mediate pyroptosis to counteract m6A methylation-based immunosuppression after insufficient radiofrequency ablation of hepatocellular carcinoma

    by Zeyu Xiao, Jiaxin Yuan, Qing Wu, Juan Qin, Yiming Liu, Siqi Zhang, Bo Sun, Ruoxue Dai, Pingping Zhang, Ni Shao, et al.


  • Open Access

    Differentiation of non-hypervascular non-functional pancreatic neuroendocrine neoplasms from solid pseudopapillary neoplasms using dual-layer spectral detector CT

    by Jiaxin Yuan, Mingjie Chen, Jiawei Liu, Liqin Wang, Minghao Zhang, Ning Zhang, Shi-Ting Feng, Luyong Wei, Siya Shi, Yanji Luo

    Dual-layer spectral detector CT (DLCT) represents an advanced and emerging modality in CT imaging, offering multiparametric images that enhance the quantitative assessment of pancreatic diseases. Non-hypervascular non-functional pancreatic neuroendocrine neoplasms (NF-pNENs) and solid pseudopapillary neoplasms (SPNs) frequently exhibit overlapping clinical and imaging features, complicating their differentiation. This study aimed to investigate the valuable quantitative parameters of DLCT in preoperative differentiation between non-hypervascular NF-pNEN and SPN, as well as to analyze their diagnostic performance. This retrospective study included 52 patients with pathologically confirmed non-hypervascular NF-pNENs and SPNs who underwent DLCT examination before surgery between June 2019 and September 2025. To differentiate between non-hypervascular NF-pNENs and SPNs, independent relevant clinical-radiological features and quantitative parameters were identified using the Least Absolute Shrinkage and Selection Operator (LASSO) regression analysis and multivariate logistic regression analysis. The diagnostic performances of independent variables were assessed through receiver operating characteristic curves. There were 34 patients with non-hypervascular NF-pNENs (46.7 ± 10.2 years, 19 females) and 18 patients with SPNs (32.8 ± 7.9 years, 14 females). Clinical, radiological features and parameters were evaluated with near-perfect agreements among two radiologists. Age and normalised iodine concentration of lesion in the arterial phase (nICa) were the independent factors for differentiating between non-hypervascular NF-pNENs and SPNs in multivariate logistic regression analysis. The areas under the receiver operating characteristic curves (AUCs) for age, nCTa and nICa in tumour differentiation were 0.855 (95% confidence interval [CI], 0.754–0.956; cutoff, 36 years), 0.797 (95% CI, 0.679–0.916; cutoff, 0.285) and 0.891 (95% CI, 0.806–0.975; cutoff, 0.147), respectively. The combined model (age + nICa) demonstrated the highest performance (AUC = 0.980; 95% CI, 0.952-1.000) when comparing to that of age (P = 0.008), nCTa (P = 0.002) and nICa (P = 0.03), with satisfactory accuracy (92.3%), sensitivity (88.2%) and specificity (100%). The DLCT parameter nICa combined with age facilitates non-invasive quantitative differentiation between non-hypervascular NF-pNENs and SPNs with satisfactory diagnostic performance. Not applicable.

  • Dual-layer spectral detector CT: a non-invasive tool for simultaneously predicting Ki-67 proliferation status and p53 mutations in pancreatic ductal adenocarcinoma

    by Jiaxin Yuan, Jiawei Liu, Mingjie Chen, Yangdi Wang, Minghao Zhang, Liqin Wang, Zhenpeng Peng, Luyong Wei, Siya Shi, Yanji Luo

    Objectives To evaluate the value of dual-layer spectral detector CT (DLCT) for predicting Ki-67 proliferation status and p53 mutations in pancreatic ductal adenocarcinoma (PDAC). Materials & methods This retrospective study included untreated patients with pathologically confirmed PDAC who underwent DLCT between June 2019 and September 2023. Independent relevant clinical-radiological features and quantitative parameters for predicting Ki-67 proliferation status and p53 mutations were identified using multivariate logistic regression analysis. The diagnostic performances of independent variables were evaluated using receiver operating characteristic curves. Results We included 92 patients (60.19 ± 11.22 years old, 61 males). There were 40 patients with high Ki-67 expression (Ki-67 ≥ 25%) and 43 patients positive for p53 mutation. The radiologists showed substantial or near-perfect inter- and intra-observer agreement in evaluating quantitative parameters. Normalised iodine concentration in the arterial phase (nICa) was the only independent predictor of Ki-67 proliferation status (p < 0.001; adjusted odds ratio [OR], 2.33; 95% confidence interval [CI]: 1.46, 3.74; cut-off, 0.0910) and p53 mutations (p < 0.001; adjusted OR, 1.35; 95% CI: 1.07, 1.71; cut-off, 0.0905) according to the multivariate logistic analysis. nICa showed satisfactory performance when using the chosen rounded cut-off value of 0.090 (easily applicable in clinical practice) in predicting Ki-67 proliferation (area under the receiver operating characteristic curve [AUC], 0.812; sensitivity, 87.5%; specificity, 75.0%) and p53 mutations (AUC, 0.731; sensitivity, 76.7%; specificity, 69.4%). Conclusion The DLCT parameter nICa enables simultaneous and non-invasive prediction of both Ki-67 proliferation status and p53 mutations in PDAC with satisfactory diagnostic efficacy.


  • Dual-energy CT improves differentiation of non-hypervascular pancreatic neuroendocrine neoplasms from CA 19-9-negative pancreatic ductal adenocarcinomas

    by Xuefang Hu, Siya Shi, Yangdi Wang, Jiaxin Yuan, Mingjie Chen, Luyong Wei, Weiwei Deng, Shi-Ting Feng, Zhenpeng Peng, Yanji Luo

    Purpose To evaluate the utility of dual-energy CT (DECT) in differentiating non-hypervascular pancreatic neuroendocrine neoplasms (PNENs) from pancreatic ductal adenocarcinomas (PDACs) with negative carbohydrate antigen 19–9 (CA 19-9). Methods This retrospective study included 26 and 39 patients with pathologically confirmed non-hypervascular PNENs and CA 19-9-negative PDACs, respectively, who underwent contrast-enhanced DECT before treatment between June 2019 and December 2021. The clinical, conventional CT qualitative, conventional CT quantitative, and DECT quantitative parameters of the two groups were compared using univariate analysis and selected by least absolute shrinkage and selection operator regression (LASSO) analysis. Multivariate logistic regression analyses were performed to build qualitative, conventional CT quantitative, DECT quantitative, and comprehensive models. The areas under the receiver operating characteristic curve (AUCs) of the models were compared using DeLong’s test. Results The AUCs of the DECT quantitative (based on normalized iodine concentrations [nICs] in the arterial and portal venous phases: 0.918; 95% confidence interval [CI] 0.852–0.985) and comprehensive (based on tumour location and nICs in the arterial and portal venous phases: 0.966; 95% CI 0.889–0.995) models were higher than those of the qualitative (based on tumour location: 0.782; 95% CI 0.665–0.899) and conventional CT quantitative (based on normalized conventional CT attenuation in the arterial phase: 0.665; 95% CI 0.533–0.797; all P < 0.05) models. The DECT quantitative and comprehensive models had comparable performances (P = 0.076). Conclusions Higher nICs in the arterial and portal venous phases were associated with higher blood supply improving the identification of non-hypervascular PNENs.